ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,193.22
0.36%
Dow Jones
39,118.86
0.00%
Gold vs US Dollar
2,337.715
0.53%
Brent Oil
85.535
0.50%
Bitcoin
62,717.96
0.19%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Propanc Biopharma Inc (PK) (PPCBD)

  7. Propanc Biopharma Inc (PK) (PPCBD) News

Propanc Biopharma (PK) (PPCBD)

Propanc Biopharma Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PPCBD
DateTimeSourceHeadlineSymbolCompany
21/06/202413:59Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
13/06/202411:10Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:PPCBDPropanc Biopharma Inc (PK)
12/06/202411:01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
05/06/202411:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
16/05/202411:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
15/05/202421:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
22/04/202417:12Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
10/04/202421:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
11/03/202419:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
20/02/202419:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
14/02/202419:47Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PPCBDPropanc Biopharma Inc (PK)
15/12/202320:57Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
07/12/202321:18Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
14/11/202320:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
03/11/202320:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
30/10/202320:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
26/10/202321:42Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
26/10/202321:07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
13/10/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:PPCBDPropanc Biopharma Inc (PK)
06/10/202322:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:PPCBDPropanc Biopharma Inc (PK)
28/09/202321:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:PPCBDPropanc Biopharma Inc (PK)
31/08/202321:08Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
31/08/202321:06Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
30/08/202321:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
29/08/202311:04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
23/08/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
21/08/202322:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
21/08/202322:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
16/08/202321:39Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
15/08/202311:10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
 Showing the most relevant articles for your search:USOTC:PPCBD

Your Recent History

LSE
JAY
Bluejay Mining
LSE
ALTN
Altyngold
LSE
POS
Plexus
LSE
ENET
Ethernity Networks
LSE
AAU
Ariana Resources
LSE
GDR
Genedrive
LSE
QBT
Quantum Blockchain Techn...
LSE
HE1
Helium One Global
LSE
GGP
Greatland Gold
LSE
ZED
Zenova
LSE
PANR
Pantheon Resources
LSE
STX
Shield Therapeutics
LSE
GCM
Gcm Resources
LSE
SYME
Supply@me Capital
LSE
TERN
Tern
LSE
GOLD
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved